Physician

Adam David Meszaros, MD

According to 2025 Medicare claims, Adam Meszaros, MD (NPI: 1780105049) practices internal medicine in the Columbia, SC market, with the plurality of this provider's patient population coming from Richland, SC. This provider's primary affiliated billing organization is ARTHRITIS CONSULTANTS, P.A. (NPI: 1023081189; TIN: 570876410) and primary practice location at 29203-6851.

Meszaros' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 157 traditional Medicare patients, billed 112,544 HCPCS/CPT codes, and received $2,068,361 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 454 prescription claims across 96 beneficiaries totaling $806,652 in drug costs, led by Enbrel (Etanercept). Open Payments data shows 85 records totaling $2,011. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $240 to $806,652. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.0M$2.1M2022 Medicare payment: $367,412 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,932,077 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,068,361 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202211615,178$367,412
202316390,010$1,932,077
2024157112,544$2,068,361

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$403K$807K2017 Drug cost: $240 (USD; Tot_Drug_Cst)2018 Drug cost: $10,535 (USD; Tot_Drug_Cst)2019 Drug cost: $9,947 (USD; Tot_Drug_Cst)2020 Drug cost: $36,114 (USD; Tot_Drug_Cst)2021 Drug cost: $415,152 (USD; Tot_Drug_Cst)2022 Drug cost: $576,499 (USD; Tot_Drug_Cst)2023 Drug cost: $298,595 (USD; Tot_Drug_Cst)2024 Drug cost: $806,652 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R16$240
201831113$10,535
20192080$9,947
20202051$36,114
202139192$415,152
202254253$576,499
202397372$298,595
202496454$806,652

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less105878$89
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more147499$87
J0129Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)4637,675$31
73120X-ray of hand, 2 views84168$22
73620X-ray of foot, 2 views83166$20

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EnbrelEtanercept281,176$298,251
Enbrel SureclickEtanercept11308$82,075
MethotrexateMethotrexate Sodium1198,465$5,755
PrednisonePrednisone1346,919$1,336
Leucovorin CalciumLeucovorin Calcium19937$607

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.85$2,011UCB, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam David Meszaros, MD?

Tedicare shows public-source Medicare data for Adam David Meszaros, MD (NPI 1780105049), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam David Meszaros, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam David Meszaros, MD?

Adam David Meszaros, MD is linked to ARTHRITIS CONSULTANTS, P.A. (billing NPI 1023081189) in the available physician profile data.

Does Adam David Meszaros, MD have Open Payments data?

Adam David Meszaros, MD has 85 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.